This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: complex diseases
Check out our OPEN ACESS article on “Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues”
March 11, 2021Nanotechnology is now opening new avenues for the treatment of cancer. Here we present a critical view on the potential of nanotechnology to improve the delivery of drugs (small molecules, monoclonal antibodies and RNA-based therapies) to tumor cells or to the tumor microenvironment. We foresee a future where the therapeutic strategy can be thoughtfully designed taking into account the tumor type, the immune status of the patient, and the nature of the active molecule. This is the era of personalized nanomedicine.
Read More